Edition:
United Kingdom

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

95.70USD
16 Nov 2018
Change (% chg)

$0.95 (+1.00%)
Prev Close
$94.75
Open
$93.95
Day's High
$96.67
Day's Low
$93.01
Volume
298,670
Avg. Vol
428,066
52-wk High
$106.69
52-wk Low
$75.84

Select another date:

Fri, May 25 2018

FDA approves BioMarin rare metabolic disorder drug, shares rise

U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.

FDA approves BioMarin rare metabolic disorder drug, shares rise

May 24 U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.

Select another date: